Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Meeting Intimation for To Consider And Approve Unaudited Financial Results (Stand-Alone & Consolidated) For The Quarter/Half Year Ended 30-09-2018.

 THYROCARE TECHNOLOGIES LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2018 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a meeting of the Board of Directors of the Company will be held on Saturday, the 3rd November 2018, at the Corporate Office of the Company, inter alia,...
25-10-2018
Bigul

Updates on Buyback Offer

 Nomura Financial Advisory and Securities (India) Private Limited ("Manager to the Buyback Offer") has submitted to BSE a copy of Post Buyback Public advertisement for the attention of Equity Shareholders/beneficial owners of Equity Shares of Thyrocare Technologies Ltd ("Target Company").
24-10-2018
Bigul

Compliances - Compliance Certificate From A Practising Company Secretary

 We are attaching Compliance Certificate dated 23-10-2018 issued by Mr. V. Suresh, Practising Company Secretary, pursuant to the Regulation 40 (9) of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Half-year ended September 30, 2018. Please take the same on record.
24-10-2018
Bigul

Compliance - Half-Yearly Compliance - Reg. 7(3)

 As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period April 1, 2018 to September 30, 2018 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share...
23-10-2018
Bigul

Shareholding for the Period Ended September 30, 2018

 Thyrocare Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here
12-10-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended September 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ramjee DoraiDesignation :- Company Secretary and Compliance Officer
11-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Krishnakumar, CIO of Sundaram Mutual Fund would be having a con-call with our Chairman & Managing Director, Dr. A. Velumani on Friday, October 05, 2018, by 10.00 A.M. There could be last minute change in timings and one or more colleagues of Mr. Krishnakumar could also participate in the call....
03-10-2018
Bigul

Corporate Action-Intimation of Buy back

 We hereby apply for buyback of securities of fully paid up equity shares of face value Rs. 10/-each from the Open Market through electronic mechanism of the Exchange. The Maximum Buyback price would not exceed Rs. 730/- (Rupees Seven Hundred and Thirty only) per equity share payable in cash for an aggregate amount not exceeding Rs. 63,00,00,000/- in accordance with provisions specified under SEBI(Buy Back of Securities) Regulations, 1998....
21-09-2018
Bigul

Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares

 This is in furtherance to, (i) our intimation letter dated July 28, 2018, regarding convening of our board meeting to approve the buyback, (ii) our letter dated August 4, 2018, informing the outcome of our board meeting held on the same date that approved the buyback of our equity shares from the open market through the stock exchange mechanism; and (iii) our shareholders meeting dated September 1, 2018, approving the buyback....
11-09-2018
Bigul

A Velumani's pointers on Thyrocare buyback

 Buyback will not change anything other than the share price.
11-09-2018
Next Page
Close

Let's Open Free Demat Account